Are Mutation Carrier Patients Different from Non-Carrier Patients? Genetic, Pathology, and US Features of Patients with Breast Cancer.

Roxana Maria Pintican Angelica ChioreanMagdalena DumaDiana FeierMadalina SzepDan EniuIulian Gabriel GoidescuSorin Dudea

Published in: Cancers (2022)

carriers account for up to one third of the ER tumors from the carrier group. Axillary US performed worse in depicting involved lymph nodes in carrier patients, compared to negative patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
early stage
patient reported outcomes
dna methylation
genome wide
neoadjuvant chemotherapy
sentinel lymph node
locally advanced
estrogen receptor